Raras
Buscar doenças, sintomas, genes...
Astrocitoma subependimário de células gigantes
ORPHA:251618CID-10 · D43.2CID-11 · 2A00.0YDOENÇA RARA

Astrocitoma são tumores (neoplasia) do sistema nervoso central (SNC) originados de um astrócito, uma célula em forma de estrela que sustenta os neurônios. É o tipo de glioma mais comum e podem ser benignos ou malignos. Quanto menor o grau, mais tempo de sobrevida, que pode ultrapassar 10 anos ou serem menor a 1 ano. Afetam 5 em cada 100.000 pessoas.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Tumor cerebral raro, geralmente benigno, originado nas paredes dos ventrículos. Caracteriza-se por células semelhantes a astrocitos com núcleos grandes e citoplasma abundante. Frequentemente associado à esclerose tuberosa.

Publicações científicas
504 artigos
Último publicado: 2026
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: D43.2
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico504PubMed
Últimos 10 anos200publicações
Pico201725 papers
Linha do tempo
2026Hoje · 2026🧪 1993Primeiro ensaio clínico📈 2017Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 24
1Fase 111
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 19 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Astrocitoma subependimário de células gigantes

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

50 ensaios clínicos encontrados.

Distribuição por fase
NCT01165632 · Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surger…Concluído
EARLY_PHASE1
NCT02186509 · Alisertib and Fractionated Stereotactic Radiosurgery in Trea…Concluído
PHASE1
NCT02654340 · Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)Encerrado
NCT00823459 · Everolimus in Treating Patients With Recurrent Low-Grade Gli…Concluído
PHASE2
NCT02194452 · Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) …Cancelado
NA
NCT02175745 · 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients …Encerrado
NA
NCT00326664 · AZD2171 in Treating Young Patients With Recurrent, Progressi…Concluído
PHASE1
NCT00789828 · Efficacy and Safety of Everolimus (RAD001) in Patients of Al…Concluído
PHASE3
NCT01119599 · RO4929097, Temozolomide, and Radiation Therapy in Treating P…Concluído
PHASE1
NCT01462695 · Sunitinib Malate in Treating Younger Patients With Recurrent…Concluído
PHASE2
NCT00112736 · Erlotinib and Temsirolimus in Treating Patients With Recurre…Concluído
PHASE1, PHASE2
NCT01088763 · Gamma-Secretase Inhibitor RO4929097 in Treating Young Patien…Encerrado
PHASE1
NCT00411619 · Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Pat…Concluído
PHASE1, PHASE2
NCT00946335 · ABT-888 and Temozolomide in Treating Young Patients With Rec…Concluído
PHASE1
NCT00063973 · Cilengitide in Treating Children With Refractory Primary Bra…Concluído
PHASE1
NCT00100880 · Lenalidomide in Treating Young Patients With Recurrent, Prog…Concluído
PHASE1
NCT00052780 · Temozolomide and O6-Benzylguanine in Treating Children With …Concluído
PHASE1
NCT00994500 · Vorinostat and Bortezomib in Treating Young Patients With Re…Concluído
PHASE1
NCT01076530 · Vorinostat and Temozolomide in Treating Young Patients With …Concluído
PHASE1
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
256 papers (10 anos)
#1

Malignant Progression of Subependymal Giant Cell Astrocytoma-Imitating Fibrous Meningioma in a Child Carrying a Germline <italic>CHEK2</italic> Mutation.

Pathobiology : journal of immunopathology, molecular and cellular biology2026 Jan 27

The subependymal giant cell astrocytoma (SEGA) predominantly occurs in patients with tuberous sclerosis. Here, we present an unusual aggressive transformation of SEGA-imitating fibrous meningioma in a child carrying a germline CHEK2 mutation. This case study was conducted at a tertiary pediatric oncology center in accordance with current diagnostic and therapeutic standards. Tumor classification followed WHO CNS5 criteria and was complemented by genome-wide DNA methylation profiling. Comprehensive molecular workup included germline and somatic whole exome sequencing, copy number analysis, and RNA sequencing. An 8.5-year-old girl presented with an intraventricular tumor initially diagnosed as SEGA based on imaging and partial resection histology. Treatment with an mTOR inhibitor led to 4 years of stability before rapid progression and death due to postoperative brain edema. Re-examination of both specimens revealed transformation into an aggressive anaplastic meningioma, while the initial lesion was reclassified as fibrous meningioma. Whole exome and microarray analyses excluded germline TSC1/TSC2 defects but identified a pathogenic germline CHEK2 variant (c.1466del, p.Asn489ThrfsTer23). Somatic alterations involving NF1 and TP53 were found in the primary tumor. Constitutional CHEK2 mutations combined with somatic NF1 defect may have promoted the malignant progression of SEGA-imitating fibrous meningioma and its favorable initial response to mTOR inhibitors.

#2

Impact of prenatal sirolimus on cardiac rhabdomyomas and brain tubers.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology2026 Mar

To document the natural progression of fetal cardiac rhabdomyomas and evaluate the impact of prenatal sirolimus (PNS) on tumor size, cardiac complications and brain-tuber size. This was a single-center retrospective cohort study of pregnancies with suspected fetal cardiac rhabdomyoma referred to our center from April 2013 to May 2024. Serial ultrasound and echocardiography reports were reviewed to obtain tumor characteristics, such as diameter and location, and cardiac complications, including inflow or outflow obstruction, arrhythmia and hydrops. The tumor-to-femur length (TFL) ratio was calculated to correct for fetal growth. Prenatal neurosonography reports were collected from clinical records. Pre- and postnatal brain magnetic resonance imaging (MRI) scans were reviewed by two observers who were blinded to PNS treatment. Brain-lesion severity was assessed based on the presence of subependymal nodules, the EPISTOP score, the maximum diameter of the largest subcortical tuber, the maximum diameter of the largest subependymal giant cell astrocytoma (SEGA) and the diameter of the largest lateral ventricle. Prenatal or postnatal genetic testing results were documented when available. Twenty-seven pregnancies were included in the study, seven of which received PNS. Prior to initiation of treatment, the diameter of the largest cardiac tumor at diagnosis was similar between the non-PNS and PNS groups (mean, 15.2 mm vs 14.3 mm; P = 0.72), with the left ventricle the most frequently affected location. Without treatment, rhabdomyomas grew rapidly from 20 + 0 to 27 + 6 weeks' gestation (mean, 2.58 mm/week) but growth slowed after 28 weeks (mean, 0.44 mm/week). Hydrops was reported in four cases and occurred at a mean tumor diameter of 31.7 ± 6.2 mm, mean TFL ratio of 0.68 ± 0.15 and at a mean growth rate of 4.3 ± 1.7 mm/week. In the seven women treated with PNS, treatment for > 7 days (n = 3) resulted in tumor regression and/or resolution of outflow obstruction, and a reduction in TFL ratio; however, prenatal cessation of treatment resulted in rebound growth (n = 2). Treatment for ≤ 7 days (n = 4) did not impact tumor size or resolve existing cardiac complications. Among the 12 cases that underwent prenatal MRI, the median EPISTOP score was 7 (interquartile range (IQR), 1-15) and the median largest lateral ventricle diameter was 8.9 (IQR, 7.0-9.7) mm; subcortical tubers and subependymal nodules were each identified in 67% of cases, and SEGAs were identified in 58%. Among the 13 cases that underwent postnatal MRI, the median EPISTOP score was 14 (IQR, 3-16) and the median largest lateral ventricle diameter was 7 (IQR, 7-8) mm; brain tubers were identified in 92% of cases. In cases with both pre- and postnatal MRI findings who received PNS for > 7 days (n = 3), on postnatal MRI compared with prenatal MRI, one patient showed no change in findings, one demonstrated a mild increase in the largest subcortical tuber diameter and one had no detectable brain tubers. Early and sustained PNS treatment was associated with reduced cardiac rhabdomyoma size and/or resolution of cardiac complications. Rebound tumor growth was observed after discontinuation of treatment. Brain tubers appeared unchanged with PNS treatment, although the sample size was too small to draw a definitive conclusion. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

#3

A rare early-onset bilateral renal cysts, focal seizures in a 1-year-old male with tuberous sclerosis and No mutation identified.

Oxford medical case reports2026 Jan

Tuberous Sclerosis Complex (TSC) is a rare genetic disorder characterized by the development of benign tumors in multiple organs. This report presents an unusual case of early-onset renal cystic disease in a 1-year-old male with TSC, despite the absence of detectable mutations in the TSC1 or TSC2 genes. Postnatal imaging revealed bilateral polycystic kidney disease by 2 months of age. The patient presented with secondary hypertension and seizures. Neuroimaging confirmed cortical tubers and a subependymal giant cell astrocytoma (SEGA), while echocardiography identified cardiac rhabdomyomas. Despite these clinical findings, genetic testing failed to detect mutations in the TSC1 or TSC2 genes. This case highlights the importance of considering TSC as a potential diagnosis in cases of early-onset renal cystic disease, even in the absence of detectable TSC gene mutations. Additionally, the case emphasizes the risk of severe renal involvement in TSC, necessitating early recognition and management.

#4

Clinical profiles of tuberous sclerosis complex: A regionally based survey.

Brain &amp; development2025 Dec

This study aimed to clarify the clinical profiles of patients with tuberous sclerosis complex (TSC) in the general population by a regionally based survey of medical facilities in a region with 7.5 million residents, and investigate differences in clinical profiles according to medical facility size and type. A survey was sent to 146 hospitals and clinics regarding clinical profiles of patients with TSC who lived in Aichi Prefecture, Japan, between 2013 and 2018. Medical facilities were classified as large hospitals (≥750 beds or a children's hospital), small hospitals (<750 beds), institutions for handicapped children, and private clinics. Information was obtained of 232 patients (median age, 25 years; range, 1-81 years). Estimated prevalence of TSC was 3.1 per 100,000. Cortical tubers were present in 88 %, epilepsy in 81 %, autism spectrum disorder in 44 %, and subependymal giant cell astrocytoma in 17 %. Hypomelanotic macules, facial angiofibroma, renal angiomyolipoma, and cardiac rhabdomyoma were present in >50 % of patients. Rates of epilepsy with frequent seizures and autism spectrum disorder were both higher in patients in institutions for handicapped children. In more than half of patients in institutions for handicapped children information on cranial MRI findings was not obtained. Our regionally based study confirmed the clinical profiles previously reported in specialized hospitals for TSC and found that clinical characteristics differed among the types and sizes of medical facilities. Multicenter information sharing and collaboration between general hospitals and institutions for handicapped children are important for the comprehensive care of patients with TSC.

#5

Successful resection of large subependymal giant cell astrocytoma using presurgical mammalian target of rapamycin inhibitor.

Surgical neurology international2025

A subependymal giant cell astrocytoma (SEGA) grows slowly near the foramen of Monro and develops in tuberous sclerosis complex patients. Large SEGA resection has a high risk of hemorrhage, resulting in irreversible sequelae. Mammalian target of rapamycin (mTOR) inhibitor has been approved for the treatment of SEGA which cannot be curatively treated surgically. An 8-year-old boy was found to have two nodules beside bilateral ventricles. After the interruption of regular examination, he was transported to the hospital with seizure, headache, and visual impairment caused by hydrocephalus. Computed tomography (CT) scan revealed two masses: one at each the left (60 × 50 × 60 mm) and right (20 × 10 × 10 mm) ventricles. An emergency ventricular outside shunt was placed, but reduction surgery could not be performed. Everolimus at 3 mg/m2 was orally administered as preoperative therapy. A reduction in tumor size was observed 2 months after everolimus initiation. Reduction surgery for the right-sided tumor was performed after discontinuation of the drug. The tumor at the left septum lucidum and caudate nucleus remained. Everolimus was administered again for residual tumor growth. After a series of surgeries, complete resection of both tumors was performed eventually. This report shows preoperative treatment using mTOR inhibitor to be an effective strategy for unresectable large SEGA.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC232 artigos no totalmostrando 197

2025

Clinical profiles of tuberous sclerosis complex: A regionally based survey.

Brain &amp; development
2026

Impact of prenatal sirolimus on cardiac rhabdomyomas and brain tubers.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2026

Malignant Progression of Subependymal Giant Cell Astrocytoma-Imitating Fibrous Meningioma in a Child Carrying a Germline <italic>CHEK2</italic> Mutation.

Pathobiology : journal of immunopathology, molecular and cellular biology
2026

A rare early-onset bilateral renal cysts, focal seizures in a 1-year-old male with tuberous sclerosis and No mutation identified.

Oxford medical case reports
2025

The Fourth Ventricle, A Rare Location for Subependymal Giant Cell Astrocytoma (SEGA): A Rare Case Report.

Clinical case reports
2025

Stereotactic radiosurgery for subependymal giant cell astrocytoma: Multi-institutional retrospective analysis of clinical and radiological outcomes.

Neurosurgical review
2025

Trifluoperazine, an Antipsychotic Drug, Inhibits Viability of Cells Derived From SEGA and Cortical Tubers Cultured In Vitro.

Journal of neurochemistry
2025

Successful resection of large subependymal giant cell astrocytoma using presurgical mammalian target of rapamycin inhibitor.

Surgical neurology international
2025

Fast-Sequence Limited Magnetic Resonance Imaging Brain Protocol for Surveillance for Subependymal Lesions and Associated Hydrocephalus in Pediatric Tuberous Sclerosis Complex.

Pediatric neurology
2025

Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: illustrative case.

Journal of neurosurgery. Case lessons
2025

A bitopic mTORC inhibitor reverses phenotypes in a tuberous sclerosis complex model.

Scientific reports
2025

Clinical Implications of Solitary Subependymal Giant Cell Astrocytoma in the Absence of Tuberous Sclerosis Complex: Case Series and Comprehensive Literature Review.

Journal of pediatric hematology/oncology
2025

Transplacental sirolimus: a new treatment strategy for life-threatening fetal cardiac rhabdomyomas-a case report.

Orphanet journal of rare diseases
2025

Glycoprotein nonmetastatic melanoma protein b immunohistochemistry can be a useful ancillary tool to diagnose subependymal giant cell astrocytoma.

Virchows Archiv : an international journal of pathology
2025

Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis.

Pediatric neurology
2025

Unusual case: Late diagnosis of tuberous sclerosis complex in a 59-year-old woman associated with extended fibrous dysplasia in craniofacial bones and spine.

Radiology case reports
2025

Stereotactic laser ablation for pediatric central nervous system tumors: a systematic review and meta-analysis of the literature.

Journal of neurosurgery. Pediatrics
2025

Epilepsy in patients with pediatric brain tumors: Etiology, treatment & management.

Seminars in pediatric neurology
2025

Neuro-Ophthalmic Characteristics of Patients with Tuberous Sclerosis Complex at a Tertiary Care Referral Centre.

Neuro-ophthalmology (Aeolus Press)
2025

Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature.

Expert review of neurotherapeutics
2025

Surgical treatment of subependymal giant cell astrocytoma in patients with tuberous sclerosis complex-an institutional experience and results.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2025

Clinical Manifestations and Treatments of Patients With Tuberous Sclerosis With Subependymal Giant Cell Astrocytoma.

Pediatric neurology
2025

Subependymal Giant Cell Astrocytoma in an Adult without Tuberous Sclerosis: Systematic Review and Illustrative Case Example.

Journal of neurological surgery reports
2025

Phenotypic clustering in tuberous sclerosis complex reveals four distinct disease trajectories.

Brain : a journal of neurology
2025

GPNMB expression differentiates subependymal giant cell astrocytoma from other mimickers.

Annals of diagnostic pathology
2024

A case of subependymal giant cell astrocytoma.

Asian journal of surgery
2024

Central nervous system manifestations of tuberous sclerosis complex: A single centre experience in Qatar.

Saudi medical journal
2025

Solitary subependymal giant cell astrocytoma lacking TSC1/2 mutations and TTF-1 expression: A potential diagnostic pitfall.

Neuropathology : official journal of the Japanese Society of Neuropathology
2024

Everolimus on cystic kidney disease burden reduction in pediatric tuberous sclerosis complex patients: a case series.

BMC nephrology
2024

TTF-1 immunohistochemistry in primary CNS tumors: A systematic review.

Clinical neuropathology
2024

Subependymal Giant Cell Astrocytoma: The Molecular Landscape and Treatment Advances.

Cancers
2024

Responsive neurostimulation of the frontal lobe for the detection and treatment of seizures in intractable epilepsy due to tuberous sclerosis complex: illustrative case.

Journal of neurosurgery. Case lessons
2024

The Clinicopathological Features of the Solitary Subependymal Giant Cell Astrocytoma: A Systematic Review.

Neurology India
2024

Complex Factors in Hydrocephalus Development in Tuberous Sclerosis Complex: A Case Report of Subependymal Giant Cell Astrocytoma.

Cureus
2024

Revealing subependymal giant cell astrocytoma with multimodal positron emission tomography: illustrative cases.

Journal of neurosurgery. Case lessons
2024

Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? A case report and review of the literature.

Journal of medical case reports
2024

Exudative Retinal Astrocytic Hamartomas and Papilledema in a Patient with Tuberous Sclerosis Complex and Subependymal Giant Cell Astrocytoma: A Case Report.

Korean journal of ophthalmology : KJO
2024

Sporadic subependymal giant cell astrocytoma with somatic TSC2 mutation: A case report.

Neurosciences (Riyadh, Saudi Arabia)
2024

Giant Retinal Astrocytoma: A Case Report of an Uncommon Presentation of Tuberous Sclerosis in a Young Female.

Case reports in neurological medicine
2024

Challenges of siblings with tuberous sclerosis showing various manifestations and severe complications.

Radiology case reports
2024

Pediatric-Like Brain Tumors in Adults.

Advances and technical standards in neurosurgery
2024

Bleeding solitary SEGA in non-tuberous sclerosis complex adolescent: a case illustration and review of literature.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

An atypical presentation of retinal astrocytic hamartoma with co-occurring SEGA in a tuberous sclerosis patient.

Radiology case reports
2024

Diagnostic utility of genetic alterations in distinguishing IDH-wildtype glioblastoma from lower-grade gliomas: Insight from next-generation sequencing analysis of 479 cases.

Brain pathology (Zurich, Switzerland)
2024

A rare case of subependymal giant cell astrocytoma presenting with spontaneous intratumoral hemorrhage.

Journal of cancer research and therapeutics
2023

Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice.

Orphanet journal of rare diseases
2023

Neoadjuvant Therapy with Everolimus for Subependymal Giant Cell Astrocytoma: A Case Report.

NMC case report journal
2024

Subependymal Giant Cell Astrocytoma Tumors in Patients Without Clinical Manifestation of Tuberous Sclerosis Complex: A Diagnostic Puzzle.

Pediatric neurology
2024

Laser interstitial thermal therapy compared with open resection for treating subependymal giant cell astrocytoma.

Journal of neurosurgery. Pediatrics
2024

SEGA-like circumscribed astrocytoma in a non-NF1 patient, harboring molecular profile of GBM. A case report.

Neuropathology : official journal of the Japanese Society of Neuropathology
2024

An updated meta-analysis of effectiveness and safety of mTOR inhibitors in the management of tuberous sclerosis complex patients.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2023

Adverse Events of Everolimus in Patients with Tuberous Sclerosis Complex Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma.

International journal of medical sciences
2023

[Circumscribed Astrocytic Gliomas].

No shinkei geka. Neurological surgery
2024

Cytological features of diffuse and circumscribed gliomas.

Cytopathology : official journal of the British Society for Clinical Cytology
2024

Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2023

Three-Year Follow-Up after Intrauterine mTOR Inhibitor Administration for Fetus with TSC-Associated Rhabdomyoma.

International journal of molecular sciences
2023

Rapamycin and rapalogs for tuberous sclerosis complex.

The Cochrane database of systematic reviews
2023

Subependymal Giant Cell Astrocytoma Non-Associated With Tuberous Sclerosis Complex and Expression of OCT-4 and INI-1: A Case Report.

Cureus
2023

Subependymal giant cell astrocytoma in the absence of tuberous sclerosis: illustrative case.

Journal of neurosurgery. Case lessons
2023

Subependymal giant-cell astrocytomas in the absence of tuberous sclerosis.

Journal of neurosurgery. Pediatrics
2023

A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors.

Pediatric neurosurgery
2023

Fetal neurosonography as accurate tool for diagnosis of brain involvement in tuberous sclerosis.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2023

Pathogenic RHEB Somatic Variant in a Child With Tuberous Sclerosis Complex Without Pathogenic Variants in TSC1 or TSC2.

Neurology
2023

Subependymal Giant Cell Astrocytoma Apoplexy: A Case Report and Systematic Review.

Cureus
2023

Enhancing the Reliability of Intraoperative Ultrasound in Pediatric Space-Occupying Brain Lesions.

Diagnostics (Basel, Switzerland)
2023

TSC2/PKD1 contiguous deletion syndrome in a pregnant woman: A case report.

Frontiers in medicine
2023

Recent management trends of subependymal giant cell astrocytoma associated with tuberous sclerosis complex.

JPMA. The Journal of the Pakistan Medical Association
2023

Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex-Current Views on Their Pathogenesis and Management.

Journal of clinical medicine
2022

Case report: 'Photodynamics of Subependymal Giant Cell Astrocytoma with 5-Aminolevulinic acid'.

Frontiers in surgery
2022

Late Manifestation of Subependymal Giant Cell Astrocytoma With Hydrocephalus in an Adult Patient With Tuberous Sclerosis Complex.

Cureus
2022

Brachial and subclavian arteries aneurysms due to tuberous sclerosis complex mechanisms - case report and literature review.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
2022

[Tuberous sclerosis complex: diagnosis and current treatment].

Medicina
2023

Therapeutic effect of everolimus on small renal angiomyolipoma in cases of tuberous sclerosis complex-related epilepsy and subependymal giant cell astrocytoma.

Asian journal of surgery
2022

Subependymal giant-cell astrocytoma: A surgical review in the modern era of mTOR inhibitors.

Neuro-Chirurgie
2022

Resection of brain lesions with a neuroendoscopic ultrasonic aspirator - a systematic literature review.

Neurosurgical review
2022

Circumscribed astrocytic gliomas: Contribution of molecular analyses to histopathology diagnosis in the WHO CNS5 classification.

Indian journal of pathology &amp; microbiology
2022

Tuber Brain Proportion Determines Epilepsy Onset in Children With Tuberous Sclerosis Complex.

Pediatric neurology
2022

Initial experience with magnetic resonance-guided focused ultrasound stereotactic surgery for central brain lesions in young adults.

Journal of neurosurgery
2022

[Subependymal Giant Cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)].

No shinkei geka. Neurological surgery
2022

Association of Early MRI Characteristics With Subsequent Epilepsy and Neurodevelopmental Outcomes in Children With Tuberous Sclerosis Complex.

Neurology
2022

Mechanistic Target of Rapamycin (mTOR) Inhibitors.

Handbook of experimental pharmacology
2022

TTF-1: A Well-Favored Addition to the Immunohistochemistry Armamentarium as a Diagnostic Marker of SEGA.

World neurosurgery
2022

Neurosurgical Considerations of Neurocutaneous Syndromes.

Neurosurgery clinics of North America
2021

The Effect of Everolimus on Subependymal Giant Cell Astrocytoma (SEGA) in Children with Tuberous Sclerosis Complex.

Iranian journal of child neurology
2022

Missed tuberous sclerosis complex with multi-system complications in a single patient.

Radiology case reports
2022

TSC2 somatic mosaic mutation, including extra-tumor tissue, may be the developmental cause of solitary subependymal giant cell astrocytoma.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2021

Clinical trial challenges, design considerations, and outcome measures in rare CNS tumors.

Neuro-oncology
2022

Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review.

Neuro-oncology
2021

A Rare Case of Isolated Intraventricular Primary Central Nervous System Lymphoma in an 85-Year-Old Man.

Asian journal of neurosurgery
2022

Cytopathological and histopathological features of cerebral granular cell astrocytoma: A case report.

Cytopathology : official journal of the British Society for Clinical Cytology
2021

Long Term Outcome and Histologic Findings of a Retinal Astrocytic Hamartoma Treated with Intravitreal Injection of Anti-VEGF: A Case Report.

Case reports in ophthalmological medicine
2022

Story of the solitary subependymal giant cell astrocytoma: A case report and literature review.

Clinical neuropathology
2021

An Israeli tuberous sclerosis cohort: the efficacy of different anti-epileptic strategies.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2021

A multistep approach to the genotype-phenotype analysis of Polish patients with tuberous sclerosis complex.

European journal of medical genetics
2021

TSC1 Mosaicism Leading to Subependymal Giant Cell Astrocytoma but Not Tuberous Sclerosis Complex.

Pediatric neurology
2021

Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients' Perspectives.

CNS drugs
2021

Hemorrhage Into a Subependymal Giant Cell Astrocytoma in an Adult With Tuberous Sclerosis: Case Report.

The neurologist
2021

Direct and indirect costs and cost-driving factors in adults with tuberous sclerosis complex: a multicenter cohort study and a review of the literature.

Orphanet journal of rare diseases
2021

Diabetes in Individuals With Tuberous Sclerosis Complex Treated With mTOR Inhibitors.

Pediatric neurology
2021

The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation.

International journal of molecular sciences
2021

Maintenance Therapy With Everolimus for Subependymal Giant Cell Astrocytoma in Patients With Tuberous Sclerosis - Final Results From the EMINENTS Study.

Frontiers in neurology
2021

Innumerable Meningiomas Arising in a Patient With Tuberous Sclerosis Complex Decades After Radiation Therapy.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2020

Bilateral Renal Angiomyolipomas and Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex: a Case Report and Review of The Literature.

Balkan journal of medical genetics : BJMG
2021

Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.

BMC neurology
2022

The clinical and paraclinical manifestations of tuberous sclerosis complex in children.

Acta neurologica Belgica
2021

Tuberous Sclerosis: A Case Report and Review of the Literature.

Cureus
2020

Solitary subependymal giant cell astrocytoma: Case report and review of the literature.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2020

Effect of everolimus on multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis complex.

Respiratory medicine case reports
2020

Familial Nervous System Tumor Syndromes.

Continuum (Minneapolis, Minn.)
2021

A solitary extraventricular subependymal giant cell astrocytoma in the absence of tuberous sclerosis.

Radiology case reports
2021

Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.

Neuropathology : official journal of the Japanese Society of Neuropathology
2021

Subependymal Giant Cell Astrocytoma in a 79-Year-Old Woman without Clinical Features of Tuberous Sclerosis: A Case Report.

Journal of neuropathology and experimental neurology
2021

The Efficacy of Everolimus for Facial Angiofibromas in Tuberous Sclerosis Complex Patients Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma.

Dermatology (Basel, Switzerland)
2021

A case of subependymal giant cell astrocytoma without tuberous sclerosis complex and review of the literature.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC).

Frontiers in neuroanatomy
2021

A case of solitary subependymal giant cell astrocytoma with histopathological anaplasia and TSC2 gene alteration.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous sclerosis complex: should we always use contrast enhancement?

Pediatric radiology
2020

Subependymal Giant-cell Astrocytoma Masquerading as Restrictive Eating Disorder and Depression in an Adolescent.

Innovations in clinical neuroscience
2020

Juvenile xanthogranuloma as a new type of skin lesions in tuberous sclerosis complex.

Orphanet journal of rare diseases
2020

Neuroimaging in tuberous sclerosis complex.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex: Modulation of MMP by MicroRNA-320d In Vitro.

Journal of neuropathology and experimental neurology
2020

Stereotactic laser ablation for subependymal giant cell astrocytomas: personal experience and review of the literature.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study.

Genetics in medicine : official journal of the American College of Medical Genetics
2020

Pediatric Low-Grade Gliomas.

Cancers
2020

Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA).

Expert opinion on pharmacotherapy
2020

The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).

Journal of neuro-oncology
2020

Fetal subependymal giant cell astrocytoma: A case report and review of the literature.

Surgical neurology international
2020

Identification of TSC1 or TSC2 mutation limited to the tumor in three cases of solitary subependymal giant cell astrocytoma using next-generation sequencing technology.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

Freiburg Neuropathology Case Conference : Intraventricular Mass Lesion in a Child.

Clinical neuroradiology
2020

Infantile atypical subependymal giant cell astrocytoma.

Neurosciences (Riyadh, Saudi Arabia)
2020

Laser interstitial thermal therapy for pediatric atypical teratoid/rhabdoid tumor: case report.

Neurosurgical focus
2020

Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2019

Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex.

Epilepsia open
2019

Treatment Patterns and Use of Resources in Patients With Tuberous Sclerosis Complex: Insights From the TOSCA Registry.

Frontiers in neurology
2020

Endoscopic Transforaminal Transchoroidal Approach to the Third Ventricle for Cystic and Solid Tumors.

World neurosurgery
2019

Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro.

Folia neuropathologica
2019

Subependymal giant cell astrocytoma harboring a PRRC2B-ALK fusion: A case report.

Pediatric blood &amp; cancer
2019

Neurological malignancies in neurofibromatosis type 1.

Current opinion in oncology
2019

Newly Diagnosed and Growing Subependymal Giant Cell Astrocytoma in Adults With Tuberous Sclerosis Complex: Results From the International TOSCA Study.

Frontiers in neurology
2019

Subependymal Giant Cell Astrocytoma Size Measurement in Tuberous Sclerosis Complex: Noncontrast vs Contrast-Enhanced 3-Dimensional T1-Weighted Magnetic Resonance Imaging (MRI).

Journal of child neurology
2019

Clinical Characteristics of Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex.

Frontiers in neurology
2019

Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology-morphological and therapeutic implications.

Oncotarget
2019

Subependymal giant cell astrocytoma: an unexpected finding during a forensic autopsy.

Acta neurologica Belgica
2019

[The Efficacy of Everolimus for Refractory Seizures in Childhood Onset Epilepsy with Tuberous Sclerosis Complex].

Brain and nerve = Shinkei kenkyu no shinpo
2020

An update on the central nervous system manifestations of tuberous sclerosis complex.

Acta neuropathologica
2019

[Ocular Phenotype and Complications in Patients with Tuberous Sclerosis Complex (TSC)].

Klinische Monatsblatter fur Augenheilkunde
2019

Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis.

Orphanet journal of rare diseases
2019

Reliability of Imaging-Based Diagnosis of Lateral Ventricular Masses in Children.

World neurosurgery
2019

Everolimus compliance and persistence among tuberous sclerosis complex patients with renal angiomyolipoma or subependymal giant cell astrocytoma.

Current medical research and opinion
2019

Glioblastoma in a patient with tuberous sclerosis.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2018

The level of microRNA 21 is upregulated by rapamycin in serum of tuberous sclerosis complex patients and subependymal giant cell astrocytoma (SEGA)-derived cell cultures.

Folia neuropathologica
2019

Longitudinal Effects of Everolimus on White Matter Diffusion in Tuberous Sclerosis Complex.

Pediatric neurology
2018

Single and staged laser interstitial thermal therapy ablation for cortical tubers causing refractory epilepsy in pediatric patients.

Neurosurgical focus
2019

Dense array EEG estimated the epileptic focus in a patient with epilepsy secondary to tuberous sclerosis complex.

Brain &amp; development
2019

Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2018

Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2018

Subependymal Giant Cell Astrocytoma: A Surveillance, Epidemiology, and End Results Program-Based Analysis from 2004 to 2013.

World neurosurgery
2018

Potent Antitumour Effects of Novel Pentabromobenzylisothioureas Studied on Human Glial-derived Tumour Cell Lines.

Anticancer research
2018

Progressive cystic lesion in a middle-aged patient with tuberous sclerosis complex: A case report.

Medicine
2018

Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1 and EXIST-2 studies.

Journal of the European Academy of Dermatology and Venereology : JEADV
2018

Atypical subependymal giant cell astrocytoma and neonatal tuberous sclerosis.

Neurology
2017

CD99: A potential Diagnostic Marker for Differentiating Sub-ependymal Giant Cell Astrocytoma From Other Mimickers: A Report of Five Cases.

Iranian journal of pathology
2018

Trapped ventricle after laser ablation of a subependymal giant cell astrocytoma complicated by intraventricular gadolinium extravasation: case report.

Journal of neurosurgery. Pediatrics
2018

Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2.

European journal of medical genetics
2018

Efficacy and safety of everolimus in patients younger than 12 months with congenital subependymal giant cell astrocytoma.

Brain &amp; development
2018

[Hemangioma arising in subependymal giant cell astrocytoma: report of a case].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2018

Retinal astrocytoma regression in tuberous sclerosis patients treated with everolimus.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2018

Different MRI-defined tuber types in tuberous sclerosis complex: Quantitative evaluation and association with disease manifestations.

Brain &amp; development
2017

Subependymal Giant Cell Astrocytoma: Associated Hyperproteinorrhachia Causing Shunt Failures and Nonobstructive Hydrocephalus - Report of Successful Treatment with Long-term Follow-up.

Asian journal of neurosurgery
2017

Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex.

PloS one
2018

The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma.

Pediatric nephrology (Berlin, Germany)
2018

Dramatic relapse of seizures after everolimus withdrawal.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2017

Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex.

World neurosurgery
2017

Implementing a Multidisciplinary Approach to Treating Tuberous Sclerosis Complex: A Case Report.

Child neurology open
2017

Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.

PloS one
2017

Pilocytic astrocytoma: A rare presentation as intraventricular tumor.

Surgical neurology international
2017

Characterization of gliomas: from morphology to molecules.

Virchows Archiv : an international journal of pathology
2017

Improvement in Renal Cystic Disease of Tuberous Sclerosis Complex After Treatment with Mammalian Target of Rapamycin Inhibitor.

The Journal of pediatrics
2017

Subependymal Giant Cell Astrocytoma Presenting with Tumoral Bleeding: A Case Report.

Brain tumor research and treatment
2017

Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus.

Pediatric neurology
2017

Some characteristics of gliomas managed at a Neurosurgery centre in Nigeria.

The Nigerian postgraduate medical journal
2017

[Hemorrhagic Onset of Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis:A Case Report and Review of Literature].

No shinkei geka. Neurological surgery
2017

[Hereditary tumor syndromes in neuropathology].

Der Pathologe
2017

Assessment of tumors in children with tuberous sclerosis: a single centre's experience.

Turk pediatri arsivi
2017

Treatment of Renal Angiomyolipoma and Other Hamartomas in Patients with Tuberous Sclerosis Complex.

Clinical journal of the American Society of Nephrology : CJASN
2017

Astrocytic tumor with large cells and worrisome features in two patients with tuberous sclerosis: drastically different diagnoses and prognoses.

Clinical neuropathology
2017

Risk factors for the development of autism spectrum disorder in children with tuberous sclerosis complex: protocol for a systematic review.

Systematic reviews
2017

Clinicopathological features and microsurgical outcomes for giant pediatric intracranial tumor in 60 consecutive cases.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2017

Initial experience with endoscopic ultrasonic aspirator in purely neuroendoscopic removal of intraventricular tumors.

Journal of neurosurgery. Pediatrics
2017

Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2017

TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.

Orphanet journal of rare diseases
2017

Causes of mortality in individuals with tuberous sclerosis complex.

Developmental medicine and child neurology
2017

Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2017

Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis (the EMINENTS study).

Pediatric blood &amp; cancer
2016

Efficacy and safety of Everolimus in children with TSC - associated epilepsy - Pilot data from an open single-center prospective study.

Orphanet journal of rare diseases
2016

[Tuberous sclerosis with infantile spasm and subependymal giant cell astrocytoma].

No to hattatsu = Brain and development
2016

Perinatal (fetal and neonatal) astrocytoma: a review.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Ver todos os 232 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Astrocitoma subependimário de células gigantes.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Astrocitoma subependimário de células gigantes

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Malignant Progression of Subependymal Giant Cell Astrocytoma-Imitating Fibrous Meningioma in a Child Carrying a Germline &lt;italic&gt;CHEK2&lt;/italic&gt; Mutation.
    Pathobiology : journal of immunopathology, molecular and cellular biology· 2026· PMID 41591989mais citado
  2. Impact of prenatal sirolimus on cardiac rhabdomyomas and brain tubers.
    Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology· 2026· PMID 41674351mais citado
  3. A rare early-onset bilateral renal cysts, focal seizures in a 1-year-old male with tuberous sclerosis and No mutation identified.
    Oxford medical case reports· 2026· PMID 41589098mais citado
  4. Clinical profiles of tuberous sclerosis complex: A regionally based survey.
    Brain &amp; development· 2025· PMID 41693132mais citado
  5. Successful resection of large subependymal giant cell astrocytoma using presurgical mammalian target of rapamycin inhibitor.
    Surgical neurology international· 2025· PMID 41030394mais citado
  6. [Features of brain involvement in tuberous sclerosis patients in the Republic of Bashkortostan].
    Zh Nevrol Psikhiatr Im S S Korsakova· 2026· PMID 41984558recente
  7. Microsurgical Resection of Subependymal Giant Cell Astrocytoma: Single-Center Retrospective Analysis and Meta-Analysis.
    Neurosurgery· 2026· PMID 41972772recente
  8. Comparative Evaluation of CT and MRI in Detecting Intracranial and Extracranial Manifestations of Tuberous Sclerosis Complex.
    Neuropsychiatr Dis Treat· 2026· PMID 41908340recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:251618(Orphanet)
  2. MONDO:0016693(MONDO)
  3. GARD:10632(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q122222(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Astrocitoma subependimário de células gigantes
Compêndio · Raras BR

Astrocitoma subependimário de células gigantes

ORPHA:251618 · MONDO:0016693
CID-10
D43.2 · Neoplasia de comportamento incerto ou desconhecido do encéfalo, não especificado
CID-11
MedGen
UMLS
C0205768
Repurposing
3 candidatos
carmustineDNA alkylating agent|DNA inhibitor
temozolomideDNA alkylating agent
everolimusmTOR inhibitor
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades